DEXCOM INC (1DXCM.MI) Fundamental Analysis & Valuation

BIT:1DXCM • US2521311074

Current stock price

62.77 EUR
+1.58 (+2.58%)
Last:

This 1DXCM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1DXCM.MI Profitability Analysis

1.1 Basic Checks

  • 1DXCM had positive earnings in the past year.
  • In the past year 1DXCM had a positive cash flow from operations.
  • 1DXCM had positive earnings in each of the past 5 years.
  • 1DXCM had a positive operating cash flow in each of the past 5 years.
1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCF1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • The Return On Assets of 1DXCM (9.61%) is better than 92.31% of its industry peers.
  • 1DXCM's Return On Equity of 26.44% is amongst the best of the industry. 1DXCM outperforms 92.31% of its industry peers.
  • 1DXCM's Return On Invested Capital of 15.72% is amongst the best of the industry. 1DXCM outperforms 92.31% of its industry peers.
  • 1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is in line with the industry average of 10.72%.
  • The last Return On Invested Capital (15.72%) for 1DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROIC 15.72%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1DXCM.MI Yearly ROA, ROE, ROIC1DXCM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • 1DXCM has a Profit Margin of 15.96%. This is amongst the best in the industry. 1DXCM outperforms 90.77% of its industry peers.
  • In the last couple of years the Profit Margin of 1DXCM has grown nicely.
  • With a decent Operating Margin value of 18.41%, 1DXCM is doing good in the industry, outperforming 73.85% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1DXCM has grown nicely.
  • With a Gross Margin value of 60.20%, 1DXCM perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1DXCM has remained more or less at the same level.
Industry RankSector Rank
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
1DXCM.MI Yearly Profit, Operating, Gross Margins1DXCM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1DXCM.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1DXCM is creating some value.
  • The number of shares outstanding for 1DXCM has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1DXCM remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
1DXCM.MI Yearly Shares Outstanding1DXCM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1DXCM.MI Yearly Total Debt VS Total Assets1DXCM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • 1DXCM has an Altman-Z score of 5.23. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
  • 1DXCM has a better Altman-Z score (5.23) than 86.15% of its industry peers.
  • The Debt to FCF ratio of 1DXCM is 2.36, which is a good value as it means it would take 1DXCM, 2.36 years of fcf income to pay off all of its debts.
  • 1DXCM's Debt to FCF ratio of 2.36 is fine compared to the rest of the industry. 1DXCM outperforms 73.85% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that 1DXCM is not too dependend on debt financing.
  • 1DXCM has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: 1DXCM outperforms 49.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Altman-Z 5.23
ROIC/WACC1.64
WACC9.58%
1DXCM.MI Yearly LT Debt VS Equity VS FCF1DXCM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • 1DXCM has a Current Ratio of 1.56. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • 1DXCM has a Current ratio (1.56) which is in line with its industry peers.
  • 1DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • 1DXCM has a better Quick ratio (1.38) than 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.38
1DXCM.MI Yearly Current Assets VS Current Liabilites1DXCM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1DXCM.MI Growth Analysis

3.1 Past

  • 1DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.67%, which is quite impressive.
  • 1DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.10% yearly.
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%

3.2 Future

  • 1DXCM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.26% yearly.
  • Based on estimates for the next years, 1DXCM will show a quite strong growth in Revenue. The Revenue will grow by 12.21% on average per year.
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
1DXCM.MI Yearly Revenue VS Estimates1DXCM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1DXCM.MI Yearly EPS VS Estimates1DXCM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1DXCM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 34.68 indicates a quite expensive valuation of 1DXCM.
  • The rest of the industry has a similar Price/Earnings ratio as 1DXCM.
  • 1DXCM is valuated rather expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 28.71, the valuation of 1DXCM can be described as expensive.
  • Based on the Price/Forward Earnings ratio, 1DXCM is valued a bit more expensive than 61.54% of the companies in the same industry.
  • 1DXCM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 34.68
Fwd PE 28.71
1DXCM.MI Price Earnings VS Forward Price Earnings1DXCM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1DXCM indicates a slightly more expensive valuation: 1DXCM is more expensive than 61.54% of the companies listed in the same industry.
  • 1DXCM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.62
EV/EBITDA 24.14
1DXCM.MI Per share data1DXCM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1DXCM may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1DXCM's earnings are expected to grow with 21.95% in the coming years.
PEG (NY)1.67
PEG (5Y)1.57
EPS Next 2Y20.72%
EPS Next 3Y21.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1DXCM.MI Dividend Analysis

5.1 Amount

  • 1DXCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1DXCM.MI Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

BIT:1DXCM (3/4/2026, 7:00:00 PM)

62.77

+1.58 (+2.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners100.29%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap24.16B
Revenue(TTM)N/A
Net Income(TTM)720.70M
Analysts84.32
Price Target74.94 (19.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)0%
PT rev (3m)-15.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 34.68
Fwd PE 28.71
P/S 6.26
P/FCF 26.62
P/OCF 19.52
P/B 10.37
P/tB 10.78
EV/EBITDA 24.14
EPS(TTM)1.81
EY2.88%
EPS(NY)2.19
Fwd EY3.48%
FCF(TTM)2.36
FCFY3.76%
OCF(TTM)3.22
OCFY5.12%
SpS10.03
BVpS6.05
TBVpS5.82
PEG (NY)1.67
PEG (5Y)1.57
Graham Number15.7
Profitability
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROCE 19.96%
ROIC 15.72%
ROICexc 77.75%
ROICexgc 88.6%
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
FCFM 23.51%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Debt/EBITDA 1.2
Cap/Depr 158.02%
Cap/Sales 8.55%
Interest Coverage 250
Cash Conversion 134.63%
Profit Quality 147.34%
Current Ratio 1.56
Quick Ratio 1.38
Altman-Z 5.23
F-Score5
WACC9.58%
ROIC/WACC1.64
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.37%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%

DEXCOM INC / 1DXCM.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI.


Can you provide the valuation status for DEXCOM INC?

ChartMill assigns a valuation rating of 2 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Overvalued.


What is the profitability of 1DXCM stock?

DEXCOM INC (1DXCM.MI) has a profitability rating of 8 / 10.


How financially healthy is DEXCOM INC?

The financial health rating of DEXCOM INC (1DXCM.MI) is 7 / 10.


Can you provide the expected EPS growth for 1DXCM stock?

The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 20.81% in the next year.